Wyss Center and Osypka announce collaboration
Pushing the boundaries of implantable neuro-device development
Today the Wyss Center for Bio and Neuroengineering, Geneva, Switzerland and OSYPKA AG/OSYPKA Medtec, Rheinfelden, Germany and Longmont, Colorado, USA, announced a collaboration to develop and integrate innovative technologies into implantable neuro-devices.
One of the major challenges of developing implantable devices that can measure brain signals is protecting the delicate internal electronics from the inhospitable, warm, wet and salty environment of the human body. Hermetic sealing – or encapsulation – of the device housing is necessary to ensure devices are leak-proof and can survive in the body for years. When the wires carrying brain signals pass into the device, through ‘feedthroughs’, there is a risk that moisture could enter. More channels of data feeding through the device housing enable more brain signals to be collected but increase the challenge of achieving truly hermetic sealing.
The collaboration will push the boundaries of exceptionally high-channel count medical implant housings by integrating new technologies and innovations in feedthroughs, hermetic sealing and biocompatible materials.
Achim Kitschmann, OSYPKA AG CEO said: “We are pleased to forge this collaboration with the Wyss Center. By leveraging OSYPKA’s decade long expertise in developing and manufacturing life-sustaining, active implantable devices we can help accelerate the Wyss Center’s mission to bring its neurotechnologies to the patient.”
Dr Mary Tolikas, Director of the Wyss Center said: “Our collaboration with OSYPKA will help us tackle some of the enormous engineering challenges involved in delivering miniaturized and viable implantable neuro-devices, eventually helping patients with nervous system disorders around the world.”
The Wyss Center is addressing some of the most serious medical conditions by accelerating the development of promising technology from lab bench to clinic. The Center is keen to harness the expertise and experience of clinical and industrial collaborators to drive development of neurotechnology that could revolutionize the diagnosis and treatment of neuro-disorders ranging from epilepsy and paralysis to tinnitus.
Dr Thorsten Göttsche, CTO / Advanced Technologies, CFO OSYPKA AG, will highlight the collaboration during his presentation ‘Pushing the boundaries of implantable device development’ at the Swiss MedTech Expo in Lucerne on 10th September 2019. Members of the Wyss Center team will also be present.
New project: Speakeasy
A new Wyss Center - University of Geneva collaboration aims to decode imagined speech directly from the brain using novel implanted electrodes and new algorithms.Technology
New project: Repairing the spinal cord
Gene therapy to boost rehabilitation success following spinal cord injury.Collaboration
New project: STAR - Solutions Through Astrocyte Research
The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.Wyss Center